KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Inventory (2017 - 2026)

ClearPoint Neuro's Inventory history spans 14 years, with the latest figure at $8.4 million for Q4 2025.

  • On a quarterly basis, Inventory rose 21.8% to $8.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.4 million, a 21.8% increase, with the full-year FY2025 number at $8.4 million, up 21.8% from a year prior.
  • Inventory hit $8.4 million in Q4 2025 for ClearPoint Neuro, up from $6.6 million in the prior quarter.
  • Over the last five years, Inventory for CLPT hit a ceiling of $9.8 million in Q1 2023 and a floor of $3.3 million in Q1 2021.
  • Historically, Inventory has averaged $7.0 million across 5 years, with a median of $7.0 million in 2024.
  • Biggest five-year swings in Inventory: surged 110.09% in 2022 and later fell 21.64% in 2025.
  • Tracing CLPT's Inventory over 5 years: stood at $4.9 million in 2021, then soared by 88.4% to $9.3 million in 2022, then dropped by 14.96% to $7.9 million in 2023, then dropped by 13.25% to $6.9 million in 2024, then increased by 21.8% to $8.4 million in 2025.
  • Business Quant data shows Inventory for CLPT at $8.4 million in Q4 2025, $6.6 million in Q3 2025, and $6.3 million in Q2 2025.